BRAF c.150C>T ;(p.I50=)

Variant ID: 7-140550001-G-A

NM_004333.4(BRAF):c.150C>T;(p.I50=)

This variant was identified in 6 publications

View GRCh38 version.




Publications:


Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia.

Nature Communications
Herling, Carmen D CD; Abedpour, Nima N; Weiss, Jonathan J; Schmitt, Anna A; Jachimowicz, Ron Daniel RD; Merkel, Olaf O; Cartolano, Maria M; Oberbeck, Sebastian S; Mayer, Petra P; Berg, Valeska V; Thomalla, Daniel D; Kutsch, Nadine N; Stiefelhagen, Marius M; Cramer, Paula P; Wendtner, Clemens-Martin CM; Persigehl, Thorsten T; Saleh, Andreas A; Altmüller, Janine J; Nürnberg, Peter P; Pallasch, Christian C; Achter, Viktor V; Lang, Ulrich U; Eichhorst, Barbara B; Castiglione, Roberta R; Schäfer, Stephan C SC; Büttner, Reinhard R; Kreuzer, Karl-Anton KA; Reinhardt, Hans Christian HC; Hallek, Michael M; Frenzel, Lukas P LP; Peifer, Martin M
Publication Date: 2018-02-20

Variant appearance in text: BRAF: I50=
PubMed Link: 29463802
Variant Present in the following documents:
  • 41467_2018_Article_3170.pdf
  • 41467_2018_3170_MOESM1_ESM.pdf
View BVdb publication page



Targeting the Hsp90 C-terminal domain to induce allosteric inhibition and selective client downregulation.

Biochimica Et Biophysica Acta. General Subjects
Goode, Kourtney M KM; Petrov, Dino P DP; Vickman, Renee E RE; Crist, Scott A SA; Pascuzzi, Pete E PE; Ratliff, Tim L TL; Davisson, V Jo VJ; Hazbun, Tony R TR
Publication Date: 2017-08

Variant appearance in text: BRAF: I50=
PubMed Link: 28495207
Variant Present in the following documents:
  • Main text
View BVdb publication page



Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.

Nature Communications
Kis, Olena O; Kaedbey, Rayan R; Chow, Signy S; Danesh, Arnavaz A; Dowar, Mark M; Li, Tiantian T; Li, Zhihua Z; Liu, Jessica J; Mansour, Mark M; Masih-Khan, Esther E; Zhang, Tong T; Bratman, Scott V SV; Oza, Amit M AM; Kamel-Reid, Suzanne S; Trudel, Suzanne S; Pugh, Trevor J TJ
Publication Date: 2017-05-11

Variant appearance in text: BRAF: 150C>T; I50I
PubMed Link: 28492226
Variant Present in the following documents:
  • ncomms15086-s3.xlsx, sheet 1
View BVdb publication page



Targeted exome sequencing reveals distinct pathogenic variants in Iranians with colorectal cancer.

Oncotarget
Ashktorab, Hassan H; Mokarram, Pooneh P; Azimi, Hamed H; Olumi, Hasti H; Varma, Sudhir S; Nickerson, Michael L ML; Brim, Hassan H
Publication Date: 2017-01-31

Variant appearance in text: BRAF: I50I
PubMed Link: 28002797
Variant Present in the following documents:
  • oncotarget-08-7852-s002.xlsx, sheet 15
View BVdb publication page



Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms.

Journal Of Visualized Experiments : Jove
Korpal, Manav M; Feala, Jacob J; Puyang, Xiaoling X; Zou, Jian J; Ramos, Alex H AH; Wu, Jeremy J; Baumeister, Timm T; Yu, Lihua L; Warmuth, Markus M; Zhu, Ping P
Publication Date: 2015-12-09

Variant appearance in text: BRAF: I50=
PubMed Link: 26710000
Variant Present in the following documents:
  • jove-106-52879.pdf
View BVdb publication page



NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor.

Oncotarget
Galvani, Elena E; Sun, Jing J; Leon, Leticia G LG; Sciarrillo, Rocco R; Narayan, Ravi S RS; Sjin, Robert Tjin Tham RT; Lee, Kwangho K; Ohashi, Kadoaki K; Heideman, Daniëlle A M DA; Alfieri, Roberta R RR; Heynen, Guus J GJ; Bernards, René R; Smit, Egbert F EF; Pao, William W; Peters, Godefridus J GJ; Giovannetti, Elisa E
Publication Date: 2015-12-15

Variant appearance in text: BRAF: I50=
PubMed Link: 26015408
Variant Present in the following documents:
  • oncotarget-06-42717.pdf
View BVdb publication page